Gender-specific methylation differences in relation to prenatal exposure to cigarette smoke

Gene

Volumn 494, Issue 1, 2012, Pages 36-43

  Murphy, Susan K ^a   Adigun, Abayomi ^a   Huang, Zhiqing ^a   Overcash, Francine ^b   Wang, Frances ^b   Jirtle, Randy L ^b   Schildkraut, Joellen M ^b   Murtha, Amy P ^a   Iversen, Edwin S ^c   Hoyo, Cathrine ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Duke University   (United States)

Author keywords

Early origins hypothesis; Imprinted gene; Pyrosequencing; Sex specific methylation effects

Indexed keywords

CIGARETTE SMOKE; RNA H19; SOMATOMEDIN B;

ADULT; ARTICLE; CIGARETTE SMOKING; DISEASE ASSOCIATION; DNA METHYLATION; EDUCATIONAL STATUS; EPIGENETICS; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MATERNAL SMOKING; NEWBORN; PLASTICITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SEX DIFFERENCE; SMOKING CESSATION; SOCIAL STATUS; THIRD TRIMESTER PREGNANCY;

ADULT; BIRTH WEIGHT; DNA METHYLATION; FEMALE; FETAL BLOOD; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; RNA, UNTRANSLATED; SEX CHARACTERISTICS; SMOKING;

EID: 84856091315     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.11.062     Document Type: Article

References (69)

1. Adkins R.M., Thomas F., Tylavsky F.A., Krushkal J. Parental ages and levels of DNA methylation in the newborn are correlated. BMC Med. Genet. 2011, 12:47.
2. Anon. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am. J. Clin. Nutr. 1998, 68:899-917.
3. Barker D.J. The fetal and infant origins of adult disease. BMJ 1990, 301:1111.
4. Barker D.J. The developmental origins of adult disease. J. Am. Coll. Nutr. 2004, 23:588S-595S.
5. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Personal. Soc. Psychol. 1986, 51:1173-1182.
6. Breton C.V., Byun H.M., Wenten M., Pan F., Yang A., Gilliland F.D. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am. J. Respir. Crit. Care Med. 2009, 180:462-467.
7. Byun H.M., Wong H.L., Birnstein E.A., Wolff E.M., Liang G., Yang A.S. Examination of IGF2 and H19 loss of imprinting in bladder cancer. Cancer Res. 2007, 67:10753-10758.
8. Catalano R., Bruckner T., Gould J., Eskenazi B., Anderson E. Sex ratios in California following the terrorist attacks of September 11, 2001. Hum. Reprod. 2005, 20:1221-1227.
9. CDC Trends in Smoking before, during, and after pregnancy - Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 31 Sites, 2000-2005. Surveill. Summ. 2009, SS-4.
10. Chao W., D'Amore P.A. IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev. 2008, 19:111-120.
11. Cruz-Correa M., et al. Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology 2004, 126:964-970.
12. Cui H. Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer. Dis. Markers 2007, 23:105-112.
13. Cui H., et al. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cancer Res. 2001, 61:4947-4950.
14. Cui H., Onyango P., Brandenburg S., Wu Y., Hsieh C.L., Feinberg A.P. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res. 2002, 62:6442-6446.
15. Cui H., et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003, 299:1753-1755.
16. Delaval K., Wagschal A., Feil R. Epigenetic deregulation of imprinting in congenital diseases of aberrant growth. Bioessays 2006, 28:453-459.
17. Dolinoy D.C., Huang D., Jirtle R.L. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13056-13061.
18. Elias S.G., et al. Urinary endogenous sex hormone levels in postmenopausal women after caloric restriction in young adulthood. Br. J. Cancer 2004, 90:115-117.
19. Elias S.G., Peeters P.H., Grobbee D.E., van Noord P.A. Breast cancer risk after caloric restriction during the 1944-1945 Dutch famine. J. Natl. Cancer Inst. 2004, 96:539-546.
20. Feinberg A.P. An epigenetic approach to cancer etiology. Cancer J. 2007, 13:70-74.
21. Feng S., Jacobsen S.E., Reik W. Epigenetic reprogramming in plant and animal development. Science 2010, 330:622-627.
22. Gluckman P.D., Cutfield W., Hofman P., Hanson M.A. The fetal, neonatal, and infant environments-the long-term consequences for disease risk. Early Hum. Dev. 2005, 81:51-59.
23. Gluckman P., Hanson M., Beedle A. Early life events and their consequences for later disease: a life history and evolutionary perspective. Am. J. Hum. Biol. 2007, 19.
24. Godfrey K.M., Barker D.J. Fetal programming and adult health. Public Health Nutr. 2001, 4:611-624.
25. Gomes M.V., Soares M.R., Pasqualim-Neto A., Marcondes C.R., Lobo R.B., Ramos E.S. Association between birth weight, body mass index and IGF2/ApaI polymorphism. Growth Horm. IGF Res. 2005, 15:360-362.
26. Heijmans B.T., Kremer D., Tobi E.W., Boomsma D.I., Slagboom P.E. Heritable rather than age-related environmental and stochastic factors dominate variation in DNA methylation of the human IGF2/H19 locus. Hum. Mol. Genet. 2007, 16:547-554.
27. Heijmans B.T., et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:17046-17049.
28. Heijmans B.T., Tobi E.W., Lumey L.H., Slagboom P.E. The epigenome: archive of the prenatal environment. Epigenetics 2009, 4:526-531.
29. Hoyo C., Murphy S.K., Jirtle R.L. Imprint regulatory elements as epigenetic biosensors of exposure in epidemiological studies. J. Epidemiol. Community Health 2009, 63:683-684.
30. Hoyo C., et al. Folic acid supplementation before and during pregnancy in the Newborn Epigenetics Study (NEST). BMC Publ. Health 2011, 11:46.
31. Huang Z., Wen Y., Shandilya R., Marks J.R., Berchuck A., Murphy S.K. High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer. Nucleic Acids Res. 2006, 34:555-563.
32. Ito Y., et al. Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum. Mol. Genet. 2008, 17:2633-2643.
33. Jirtle R.L., Skinner M.K. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 2007, 8:253-262.
34. Katari S., et al. DNA methylation and gene expression differences in children conceived in vitro or in vivo. Hum. Mol. Genet. 2009, 18:3769-3778.
35. Khashan A.S., et al. Risk of affective disorders following prenatal exposure to severe life events: a Danish population-based cohort study. J. Psychiatr. Res. 2011, 45:879-885.
36. Kota S.K., Feil R. Epigenetic transitions in germ cell development and meiosis. Dev. Cell 2010, 19:675-686.
37. Martin T.R., Bracken M.B. Association of low birth weight with passive smoke exposure in pregnancy. Am. J. Epidemiol. 1986, 124:633-642.
38. Mathers J.C. Early nutrition: impact on epigenetics. Forum Nutr. 2007, 60:42-48.
39. McGowan P.O., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 2009, 12:342-348.
40. Morison I.M., Reeve A.E. Insulin-like growth factor 2 and overgrowth: molecular biology and clinical implications. Mol. Med. Today 1998, 4:110-115.
41. Murphy S.K., Jirtle R.L. Imprinting evolution and the price of silence. Bioessays 2003, 25:577-588.
42. Murphy S.K., et al. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. Mol. Cancer Res. 2006, 4:283-292.
43. Murrell A., et al. Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer. PLoS One 2008, 3:e1849.
44. Nakagawa H., Chadwick R.B., Peltomaki P., Plass C., Nakamura Y., de La Chapelle A. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:591-596.
45. Painter R.C., Roseboom T.J., Bleker O.P. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod. Toxicol. 2005, 20:345-352.
46. Paradowska A., et al. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia. Int. J. Oncol. 2009, 35:87-96.
47. Pliushch G., et al. Extreme methylation values of imprinted genes in human abortions and stillbirths. Am. J. Pathol. 2010, 176:1084-1090.
48. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer 2008, 8:915-928.
49. Portela A., Esteller M. Epigenetic modifications and human disease. Nat. Biotechnol. 2010, 28:1057-1068.
50. Ravelli G.P., Stein Z.A., Susser M.W. Obesity in young men after famine exposure in utero and early infancy. N. Engl. J. Med. 1976, 295:349-353.
51. Ravelli A.C., van Der Meulen J.H., Osmond C., Barker D.J., Bleker O.P. Obesity at the age of 50 y in men and women exposed to famine prenatally. Am. J. Clin. Nutr. 1999, 70:811-816.
52. Ravenel J.D., et al. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. J. Natl. Cancer Inst. 2001, 93:1698-1703.
53. Riccio A., et al. Inherited and sporadic epimutations at the IGF2-H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumor. Endocr. Dev. 2009, 14:1-9.
54. Roth S.M., et al. IGF2 genotype and obesity in men and women across the adult age span. Int. J. Obes. Relat. Metab. Disord. 2002, 26:585-587.
55. Shetty P.J., et al. Regulation of IGF2 transcript and protein expression by altered methylation in breast cancer. J. Cancer Res. Clin. Oncol. 2010, 137:339-345.
56. Steegers-Theunissen R.P., et al. Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS One 2009, 4:e7845.
57. Stillman R.J., Rosenberg M.J., Sachs B.P. Smoking and reproduction. Fertil. Steril. 1986, 46:545-566.
58. Sullivan M.J., Taniguchi T., Jhee A., Kerr N., Reeve A.E. Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation. Oncogene 1999, 18:7527-7534.
59. Takai D., Gonzales F.A., Tsai Y.C., Thayer M.J., Jones P.A. Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. Hum. Mol. Genet. 2001, 10:2619-2626.
60. Takano Y., Shiota G., Kawasaki H. Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer. Oncology 2000, 59:210-216.
61. Taniguchi T., Sullivan M.J., Ogawa O., Reeve A.E. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:2159-2163.
62. Tellez-Plaza M., Navas-Acien A., Crainiceanu C.M., Sharrett A.R., Guallar E. Cadmium and peripheral arterial disease: gender differences in the 1999-2004 US National Health and Nutrition Examination Survey. Am. J. Epidemiol. 2010, 172:671-681.
63. Tong V.T., Jones J.R., Dietz P.M., D'Angelo D., Bombard J.M. Trends in smoking before, during, and after pregnancy - Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 31 sites, 2000-2005. MMWR CDC Surveill. Summ. 2009, 58:1-29.
64. Waterland R.A., et al. Season of conception in rural gambia affects DNA methylation at putative human metastable epialleles. PLoS Genet. 2010, 6:e1001252.
65. Wong H.L., et al. Rapid and quantitative method of allele-specific DNA methylation analysis. Biotechniques 2006, 41:734-739.
66. Xiao D., Huang X., Yang S., Zhang L. Direct effects of nicotine on contractility of the uterine artery in pregnancy. J. Pharmacol. Exp. Ther. 2007, 322:180-185.
67. Xu W., Fan H., He X., Zhang J., Xie W. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR. J. Exp. Clin. Cancer Res. 2006, 25:543-547.
68. Yajnik C.S. Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. J. Nutr. 2004, 134:205-210.
69. Zuo Q.S., et al. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer. Mol. Carcinog. 2011, 50:390-396.